| Patent application number | Description | Published |
|---|
| 20080200498 | Pharmaceutical Composition For The Treatment Of Disorders Of Sexual Desire - The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the for the treatment of sexual desire disorders. | 08-21-2008 |
| 20080242678 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 10-02-2008 |
| 20080242679 | Benzimidazolone Derivatives For the Treatment of Premenstrual and Other Female Sexual Disorders - The invention relates to the use of benzimidazolone derivatives of formula (I) for the preparation of a medicament for the treatment of premenstrual and other female sexual disorders. | 10-02-2008 |
| 20090023712 | Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin - The invention relates to new pharmaceutical compositions for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment ADHD and methods for the preparation thereof. | 01-22-2009 |
| 20090137545 | Compounds - The present invention relates to compounds of general formula I | 05-28-2009 |
| 20090176698 | Benzimidazolone Derivatives for the Treatment of Urinary Incontinence - The invention relates to compositions comprising benzimidazolone derivatives of formula (I), optionally in form of the free base or in form of the pharmacologically acceptable acid addition salts thereof and methods of treating or preventing urinary incontinence, comprising the administration of a therapeutically effective amount of compound of formula (I), wherein R | 07-09-2009 |
| 20090247546 | Treatment of Prevention of Valvular Heart Disease with Flibanserin - The invention relates to a method for the treatment or prevention of Valvular Heart Disease comprising the administration of a therapeutically effective amount of flibanserin. | 10-01-2009 |
| 20090312242 | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND RELATED DISEASES - The invention relates to the use of Flibanserin for the treatment or prevention of urinary incontinence and related diseases. In a further embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment or prevention of urinary incontinence and related diseases. | 12-17-2009 |
| 20100022558 | TREATMENT OF INSOMNIA - The invention relates to the use of Flibanserin for the preparation of medicaments useful for the treatment of Insomnia. | 01-28-2010 |
| 20100197664 | NOVEL B1-ANTAGONISTS - Disclosed are compounds of the formula I | 08-05-2010 |
| 20100240669 | NEW COMPOUNDS - The present invention relates to the compounds of general formula I | 09-23-2010 |
| 20110021488 | New Compounds - The present invention relates to compounds of general formula I | 01-27-2011 |
| 20110046106 | ARYL SULFONAMIDES AS EFFECTIVE ANALGESICS - The present invention relates to compounds of general formula I | 02-24-2011 |
| 20110077231 | COMPOUNDS - Novel compounds, with the following being exemplary: | 03-31-2011 |
| 20110098282 | NEW COMPOUNDS - Novel compounds of which the following is exemplary: | 04-28-2011 |
